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Research
AbstrACt
Objectives Vitiligo is a relatively common autoimmune 
condition causing loss of skin pigment. Around 1 in 100 
people in the UK develop vitiligo. It can have a significant 
impact on quality of life for many of those affected. How 
people access information and help for vitiligo may 
influence how they manage such impact. We aimed to 
explore people’s views and experiences of seeking health 
information and help for vitiligo.
Design Qualitative analysis of free-text responses to four 
open-ended questions in an online survey.
setting Online survey conducted in the UK between 
February and March 2016.
Participants A survey link was emailed to 675 members 
of The Vitiligo Society, a UK-based charity providing 
information and support for people with vitiligo. One 
hundred and sixty-one members responded to the survey 
(24%).
results Many participants wrote extensive free text, 
often reporting frustration with help-seeking. They 
perceived general practitioners (GP) as their primary 
source of advice but felt that GPs had low awareness of 
available treatments. Where GPs appeared sympathetic 
or signposted towards further information this was 
appreciated, even where people felt their GP had not 
seemed knowledgeable. Many felt that vitiligo was 
dismissed by health professionals including GPs and 
dermatologists as ‘cosmetic’, which upset those who 
experienced substantial impact. Participants expressed 
concerns about the credibility of online information on 
vitiligo and the need for reliable, detailed information, 
as well as a desire for support with managing its 
psychosocial impact.
Conclusions Information and help-seeking needs of 
people with vitiligo currently appear to be poorly met, even 
among members of The Vitiligo Society, who are likely 
to have received more information than others. People 
with vitiligo would welcome greater health professional 
awareness of available vitiligo treatments. Acknowledging 
the psychosocial impacts of vitiligo and signposting 
towards credible information are also welcomed.
IntrODuCtIOn
Vitiligo is an autoimmune disease where pale 
white patches progressively develop on the 
skin due to loss of pigment. Worldwide prev-
alence ranges from 0.5% to 2% and around 
1 in 100 people in the UK develop vitiligo.1 2 
The appearance altering nature of vitiligo can 
have a significant impact on quality of life, 
particularly in terms of increased anxiety, 
lowered self-esteem and relationship difficul-
ties, and it may also negatively affect self-con-
fidence and body image.3 4 Most vitiligo 
develops before the age of 20 and may have 
a profound impact on confidence and self-
image at a key time in social development.5 
The evidence base for vitiligo treatment 
is currently poor.6 A European guideline 
has suggested that early treatment of small 
lesions of recent-onset and childhood vitiligo 
should be treated with a combination of 
phototherapy and topical agents, such as 
topical corticosteroids or topical calcineurin 
inhibitors.7 Such treatments are less likely to 
be used if people with vitiligo do not consult 
strengths and limitations of this study
 ► We employed an efficient yet relatively underused 
method of qualitative data collection to explore an 
under-researched topic area.
 ► Conducting an exploratory qualitative analysis of 
the free-text comments within a quantitative survey 
allowed us to gain novel and valuable insights into, 
and a greater understanding about, the experiences 
of people with vitiligo in seeking information and 
treatment about their condition.
 ► A limitation of this study was our sampling method. 
Members of The Vitiligo Society may not be 
representative of all people with vitiligo, which limits 
the transferability of our findings. Participants in this 
study could have had greater impact from vitiligo, 
have  been more unsatisfied with the information 
they had received, or more engaged with seeking 
treatment and information than other people with 
vitiligo.
 ► Also most of the participants in this study were 
over 45, which is likely to be unrepresentative of 
the whole population of people with vitiligo as the 
condition commonly appears before the age of 20.
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health professionals or do not receive appropriate advice 
from health professionals.
Previous research has highlighted the psychosocial 
impact of vitiligo and the coping strategies adopted by 
people living with vitiligo. A survey carried out among 
members of The Vitiligo Society in 2010 showed that over 
half (56.6%) of respondents felt that vitiligo moderately 
or severely affected their quality of life.8 One qualita-
tive interview study carried out with seven white British 
women reported a continuous struggle using avoidance, 
concealment and cognitive strategies to try to deal with 
the impact of vitiligo.9 Another qualitative interview study 
was conducted with seven British women of South Asian 
descent. All had experienced stigmatisation to some 
extent. Avoidance and concealment were commonplace, 
as was a profound impact on their relationships and sense 
of identity.10
How people access and make sense of information, 
and seek help for vitiligo, is likely to influence how they 
cope with the psychosocial impacts, but there is relatively 
little research on people’s experiences of obtaining infor-
mation and treatment for vitiligo. Previous quantitative 
research suggests that people with vitiligo typically want to 
find a lasting effective treatment but they appear to have 
difficulty accessing treatment and feel that their condi-
tion is dismissed as ‘trivial’ or ‘cosmetic’.8 11 Members of 
The Vitiligo Society have reported that they obtain infor-
mation about vitiligo from non-medical sources, such as 
The Vitiligo Society (83%) and the internet (25%) rather 
than from dermatologists (13%) and general practi-
tioners (GP) (7%).8 Surprisingly few had obtained advice 
from GPs or dermatologists. Further research is needed 
to explore whether this relates to difficulties in accessing 
advice or whether people actively choose to obtain advice 
elsewhere.
Qualitative methods are well suited to exploring a 
topic in-depth from the perspective of a particular group 
of people. Qualitative research that seeks to explore 
people’s experiences of obtaining information about 
vitiligo and their help-seeking behaviour could help 
determine whether people with vitiligo expect GPs or 
dermatologists to advise them about vitiligo or whether 
they generally seek information from charities or the 
internet instead of, or in addition to, consulting. This 
in turn would enable better understanding of how GPs 
and dermatologists can best support people with vitiligo 
in terms of information provision and/or signposting 
to reliable resources. Given the potential insights into 
people’s experiences to be gained by using qualitative 
methods,12 we incorporated open-ended questions into a 
quantitative survey about information and help-seeking 
behaviour in people with vitiligo. We aimed to explore 
views and experiences of seeking information and help 
for vitiligo through analysis of the written accounts of 
survey respondents.
MethODs
This study sought to qualitatively analyse the free-text 
comments within a quantitative survey that focused on 
exploring sources of information for vitiligo, experiences 
of treatment and information needs. This qualitative 
approach has been previously used in other health-re-
lated research.13–15 
Main survey
An anonymous online survey of people with vitiligo was 
conducted in the UK in February 2016 (response rate 
161/675 (24%)). We sought participants through The 
Vitiligo Society partly because this had been a successful 
route for previous research,8 and also because informal 
advice suggested vitiligo might not be well coded in 
primary care so recruiting through this route would 
be problematic. Details about the study and a link to 
the online survey were emailed to 675 members of The 
Vitiligo Society. A reminder email was sent out after 2 
weeks. The survey link was also made available on The 
Vitiligo Society web site from February to March 2016. 
Participants provided online informed consent prior to 
accessing the survey. In total, 161 people completed some 
or all of the survey questions and were included in the 
analysis (table 1). Quantitative survey findings regarding 
sources of information and help-seeking were similar to 
those previously reported.8 This paper focuses on the rich 
qualitative data obtained from the free-text responses to 
open-ended questions in the survey.
Qualitative component
The online survey included four open-ended questions, 
which allowed participants to respond in more detail 
(table 2). The survey data set was imported into NVivo 
V.10 and responses to the open-ended questions collated 
for analysis. A total of 495 responses to the open-ended 
questions (20 728 words) were received from 158 of the 
161 survey respondents (98% of respondents completed 
the free-text questions in addition to the other survey 
questions). Responses to the open-ended questions 
ranged from brief comments (one phrase or sentence) 
to more detailed accounts (a couple of paragraphs). 
Question 3 (informational needs of people with vitiligo) 
received the most responses and question 2 (experi-
ences of seeking treatment for vitiligo) received the most 
detailed comments.
Data analysis
An inductive thematic analysis was conducted to explore 
people’s experiences of seeking information and help for 
vitiligo.16 One author (ET) read the comments several 
times to achieve familiarisation with the data and codes 
were applied line by line. Codes were derived inductively 
from the data and grouped together to produce an initial 
coding frame. Codes were compared to identify similari-
ties and differences. A detailed coding manual (containing 
code names, code descriptions and data excerpts) was 
created to ensure transparent and systematic coding of 
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the data. Codes and theme/subtheme definitions were 
discussed with recourse to the data, and iteratively devel-
oped by three members of the research team (ET, MS and 
IM) to offer diverse inferences and interpretation of the 
data. A negative case analysis was carried out to ensure 
that all data were taken into account rather than just 
selecting data that fitted with the authors’ viewpoint. Data 
saturation could not be determined due to the nature of 
the method of data collection. Using NVivo enabled a 
detailed audit trail to be maintained.
results
The majority of survey respondents (n=158, 98%) 
completed the open-ended questions, suggesting that 
those who responded to the survey were highly moti-
vated to provide written feedback on their experiences 
of seeking help and information for vitiligo. Analysis of 
these data highlighted three themes: (1) experiences of 
consulting health professionals for vitiligo; (2) seeking 
information about vitiligo; and (3) perceptions and expe-
riences of vitiligo treatments. These themes are explored 
in detail below. All quotes are labelled with a participant 
ID, gender and age.
experiences of consulting health professionals for vitiligo
A sense of dissatisfaction and feeling unsupported was 
apparent in participants’ reports about their experiences 
of consulting health professionals for vitiligo. Partici-
pants often seemed disappointed by the response they 
had received from GPs, who were viewed as their primary 
source of contact and advice. A common perception 
among participants was that GPs are not generally aware 
of, or particularly knowledgeable about, vitiligo and as 
such can only provide limited information and advice to 
patients.
None of the GPs I have spoken to have ever offered 
advice about Vitiligo. They seem to be somewhat in 
the dark about the problem. (Participant 36, male, 
over 65 years)
Where health professionals appeared sympathetic 
or where signposting towards further information was 
offered this was appreciated, even where people felt their 
GP had not been knowledgeable.
I have had vitiligo for about 35 years. I am now 70 
years old. I have found that, with very few exceptions, 
GPs know little about the condition. One of my GPs 
(who ‘half-retired’ a few years ago) was always inter-
ested in learning more and asked me if I could pro-
vide some information on vitiligo. I gave her some 
printed material and she was grateful; I know that she 
read everything which I provided. (Participant 110, 
male, over 65 years)
Many participants felt they had just been left to ‘get 
on with it’ and learn to accept and manage their viti-
ligo on their own. For some participants this led them 
to seeking out alternative treatments not available in the 
UK. Another dominant perspective in this study was the 
sense that vitiligo is not taken seriously by medical profes-
sionals, both GPs and dermatologists. Many participants 
felt that their vitiligo was dismissed by health professionals 
Table 1 Survey respondents’ characteristics
Number of 
participants
n=161
Percentage 
(%)
Answered for themselves 151 93.8 
Answered on behalf of 
other person 
4 2.5 
Missing 3 3.7 
Gender 
  Male 55 34.1 
  Female 98 60.9 
  Missing 8 5.0 
Age (years) 
  5–16 2 1.2 
  16–25 8 5.0 
  26–45 27 16.8 
  46–65 73 45.3 
  65+ 45 28.0 
  Missing 6 3.7
Portion of skin affected
  Just a few patches 
(0%–10%) 
35 21.7 
  A fair amount (10%–
25%) 
41 25.5 
  Quite a lot (25%–50%) 33 20.5 
  Very much (50%–80%) 25 15.5 
  All or nearly all (more 
than 80%)
19 11.8 
  Missing 8 5.0 
Skin colour 
  Fair 67 41.6 
  Medium 75 46.6 
  Dark 10 6.2 
  Very dark 1 0.6 
  Missing 8 5.0 
Family with vitiligo 
  Yes 72 44.7 
  No 82 50.9 
  Missing 7 4.4
Living 
  UK 147 91.3 
  Europe 1 0.6 
  Elsewhere 5 3.1
  Missing 8 5.0
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as something inconsequential, that is, purely cosmetic, 
which was upsetting to those experiencing substantial 
psychosocial impact.
I started my first signs of Vitiligo 30 years ago at the 
age of 40. I went to my GP who referred me to a con-
sultant. The consultant proved to be absolutely use-
less in providing any information. He just took one 
look at me, told me it was something called Vitiligo 
and told me that it would most likely get worse but 
wouldn't kill me!!! (Participant 71, female, over 65 
years)
I noticed most doctors don’t know much about vitiligo 
and really don’t seem to care. I felt they had no clue 
about what a person with vitiligo goes through, Since 
it’s not a matter of life or death, your expected to just 
accept it. I was very disappointed every time, always 
left feeling hopeless. I think they should have more 
to offer, be sympathetic & at least try different things. 
(Participant 138, female, 46–65 years)
seeking information about vitiligo
Participants commonly reported seeking information 
from other sources, predominantly online resources, 
as a result of receiving limited information from health 
professionals. The Vitiligo Society was viewed as a helpful 
and trustworthy source of information for participants 
but many expressed doubts about the reliability and cred-
ibility of other online resources about vitiligo. A common 
concern expressed by the participants related to the cred-
ibility of online information on possible treatments for 
vitiligo. In particular, they expressed doubts about the 
commercial interests of the web sites and about being 
able to determine the evidence base (safety and efficacy) 
of certain products and procedures.
I find it very difficult to find clear and consistent ad-
vice on possible treatments for Vitiligo. There are a 
lot of commercially orientated websites promoting 
a variety of herbal cures etc but limited proper evi-
dence based medical guidance. (Participant 40, male, 
26–45 years)
The only problem when searching for vitiligo sites is 
that some websites eventually lead into selling some 
sort of product which is the new ‘best treatment’. 
You find that because you are motivated to find 
some sort of treatment you end up almost believing 
the hype that they sell. (Participant 139, male, 46–65 
years)
A desire for detailed, reliable information about the 
causes of vitiligo, its progression and possible treatments 
was widely expressed. Some participants felt it important 
that such information should come directly from health 
professionals or other resources perceived to be trust-
worthy such as NHS Choices. Participants also expressed 
a desire for information and advice about managing the 
psychosocial impact of living with vitiligo, particularly 
advice on learning to cope with social situations and 
people's reactions to their altered appearance, and how 
to explain the condition to others.
I developed vitiligo 42 years ago when I was 2. The 
GP referred me to a very good dermatologist who 
explained things clearly as well as, crucially, how to 
sensibly explain it to other children. (Participant 11, 
female, 26–45 years)
I would like more information on the cause of it and 
how to deal with being so self-conscious about it—
it does affect confidence and forming relationships. 
(Participant 130, female, 26–45 years)
Perceptions and experiences of vitiligo treatments
Experiences of vitiligo treatments expressed by partici-
pants were very mixed. While some participants expressed 
positive experiences of treatment, particularly ultravi-
olet (UV) light treatment, many participants appeared to 
have more negative experiences of seeking and receiving 
treatment for their vitiligo. A commonly expressed view 
was that vitiligo treatment is not routinely offered or is 
poorly available, especially on the NHS, and is limited to 
particular geographical locations.
We decided to have light treatment. My main concern 
was the Vitiligo on my face. The treatment worked 
well but a few years later it appeared elsewhere on 
my face so I had more treatment that also worked 
well. The spread of vitiligo has slowed to almost a 
Table 2 Open-ended questions in survey
Questions
Number of 
responses to each 
question (%)
Total number 
of words per 
question
Q1. We would be very interested to learn more about your experience of getting 
information for vitiligo. If you are happy to, please can you tell us some more about 
this?
142 (90) 5419
Q2. We would be very interested to learn more about your experience of getting 
treatment for vitiligo. If you are happy to, please can you tell us some more about this?
103 (65) 6634
Q3. Are there any aspects of vitiligo that you feel you would like to know more about? 148 (94) 3682
Q4. Is there anything you would like to say that you feel has not been covered already? 102 (65) 4993
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stop apart from a couple of new areas on my face. 
(Participant 74, male, 46–65 years)
There is very little treatment for Vitiligo in the UK. I 
am at present involved with the Hi-Light trial run by 
the Univ of Nottingham. This is the first time I have 
been able to obtain any treatment. (Participant 102, 
male, over 65 years)
Many participants, who had received treatments 
such as steroid creams and light treatment for their 
vitiligo, felt they were ineffective in the long term as 
the treatments had been unsuccessful in maintaining 
any areas of repigmentation. Participants also reported 
the perceived difficulties and potential side effects of 
vitiligo treatment such as concerns about skin thinning 
with steroid creams, time-consuming nature and incon-
venience of hospital-based UV light treatment and the 
physical side effects of light treatment such as nausea 
and headaches.
I was referred to Dermatology and was prescribed 
PUVA treatment. This helped for a while, but became 
so time consuming. Progress was very slow. I stopped 
the treatment and any areas of repigmentation 
soon reverted back to white skin. So disappointing. 
(Participant 156, female, 46–65 years)
As well as mixed experiences of vitiligo treatments, 
there were mixed attitudes towards the need to seek viti-
ligo treatments in the first instance. Some participants 
reported less experience of treatments because they had 
not sought these out and had ‘accepted’ their vitiligo, 
even though it may have had a profound impact on their 
lives.
I think that vitiligo is a relatively unknown condition. 
I have never been contacted about treatment or had 
it offered to me despite having had the condition for 
many years. You are very much left to get on with it. 
I can imagine that some people suffer psychological-
ly and I wonder what support they get. I have come 
to terms with my patches and embrace them rather 
than disguise them but it can feel quite disheartening 
at times and I would rather not have them given the 
choice. (Participant 58, female, 46–65 years)
DIsCussIOn
We found predominantly negative experiences of 
help-seeking, concerns about the credibility of online 
information and the need for detailed, reliable vitiligo 
information. Frustration with challenges to help-
seeking was often reported, particularly perceived lack 
of awareness of available treatments among GPs. Many 
felt that vitiligo was often dismissed by health profes-
sionals as ‘cosmetic’, which was upsetting to those expe-
riencing substantial psychosocial impact. Where GPs 
appeared sympathetic or where signposting towards 
further information was offered this was appreciated, 
even where people felt their GP had not seemed knowl-
edgeable. There were very mixed views about the need 
for treatment and a desire for support with managing 
the psychosocial impact of vitiligo.
This study provides valuable insights into the expe-
riences of people with vitiligo in seeking information 
and treatment about their condition. We employed an 
efficient yet relatively underused method of qualitative 
data collection to explore an under-researched topic 
area. Given the relative anonymity of providing written 
responses in an online survey, these data may have 
been more candid than data collected in face-to-face 
research settings. However, it was not possible in this 
context to ask participants to expand on or clarify their 
free-text responses. Being able to clarify and explore 
further views and experiences of patients with vitiligo in 
a qualitative interview may have generated richer data 
that would have enabled a more in-depth qualitative 
analysis.
Our findings also need to be seen in the context of our 
sampling method. People with vitiligo who are members 
of The Vitiligo Society may not be representative of all 
people with vitiligo. Members of The Vitiligo Society 
pay an annual membership fee (£26), which may be a 
barrier to membership for some people. The response 
rate for our survey, which was carried out entirely online, 
was lower than the previous survey among The Vitiligo 
Society members,8 which was carried out by post. We 
did not compare responders with non-responders and 
so we cannot be sure that our participants are different 
in some way from those who did not respond to the 
survey. This may mean that participants in this study 
had greater impact from vitiligo, were more unsatisfied 
with the information they had received, or were more 
engaged with seeking treatment and information than 
other people with vitiligo, and limits the transferability 
of the findings
Most of the participants in this study were over 45, 
which is likely to be unrepresentative of the whole popu-
lation of people with vitiligo as the condition commonly 
appears before the age of 20.17 18 It is likely that most 
of the participants had had vitiligo for many years and 
their experience may differ from those more recently 
diagnosed. Furthermore, by sampling through a patient 
support group we may have been more likely to receive 
accounts from people whose needs had not been met 
by health services, although it is notable that this group 
still felt that they had many unanswered questions and 
that they found online information difficult to navigate.
The feeling that vitiligo is dismissed by health profes-
sionals as ‘cosmetic’ or ‘trivial’ shows that this is an 
ongoing concern for people, in common with previous 
reports,9 10 and also in line with other skin condi-
tions.19 20 We found that people can find it difficult to 
judge the credibility of online information on vitiligo, 
as in other conditions,21 but it seems surprising in this 
context where participants are all members of a rele-
vant support group. We also found that participants 
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still generally view health professionals as an important 
source of information, which has been noted in other 
studies.22 Again, it seems surprising that our partici-
pants, who were members of a support group and many 
of whom reported negative experiences of consulting, 
still wanted health professionals to be the main source 
of information. Our finding that people are keen for 
support with managing the psychosocial impact of 
living with vitiligo was also found in a recent James 
Lind Alliance Priority Setting Partnership in the UK, 
which identified the need for further research into the 
effectiveness of psychological support for people with 
vitiligo, either on its own or together with other treat-
ments.23 The importance of providing people with skin 
diseases with access to a range of supportive services 
including psychological support was also acknowledged 
in a recent report of the All Party Parliamentary Group 
on Skin.24
Constraints on access to specialists through primary 
care ‘gatekeeping’ or ‘managed care’ may be associated 
with lower patient satisfaction,25 and respondents in 
this study expressed frustration with generalist services, 
perceiving them to have a low level of knowledge about 
their condition. It is not completely clear whether this 
represents lack of awareness among GPs of available 
treatments for vitiligo, or lack of provision of services 
into which they can refer. Access to vitiligo services/
treatment is becoming increasingly difficult in many 
areas of the UK, which is likely to increase people’s 
frustration with help-seeking and may exacerbate the 
psychosocial impact experienced by many people with 
vitiligo.
This paper highlights opportunities for further qual-
itative and quantitative research exploring and exam-
ining the needs of people with vitiligo, particularly 
younger people with vitiligo and those with a recent 
diagnosis. There is also a paucity of comparative 
evidence for effective treatments for vitiligo. In addition 
to quantitative research examining the effectiveness of 
treatments, greater evidence is also needed on how 
best to address the psychosocial impact of living with 
vitiligo. In this study, people’s support needs included 
advice on managing social situations and explaining the 
condition to others, learning how to use camouflage, as 
well as clear and up-to-date information about the pros 
and cons of available treatments. Further research to 
develop and test education and psychological support 
interventions that seek to address the information and 
support needs of people with vitiligo is likely to be valu-
able. In an era where people are increasingly obtaining 
health information online,26 it may be that education 
and psychological support interventions delivered 
online may be beneficial.
In conclusion, more can be done to meet the infor-
mation and help-seeking needs of people with vitiligo. 
People with vitiligo would welcome greater health profes-
sional awareness of the possibility of treating vitiligo, yet 
recognise that generalist services may not always be able to 
offer this. People who had been directed towards reliable 
information were very grateful for this and signposting 
is viewed as a key role of GPs, which remain the primary 
source of information for many. Fortunately, good online 
resources for people with vitiligo are available (table 3). 
Signposting people with vitiligo towards credible online 
resources and acknowledging and exploring the poten-
tial impact of the condition may allay people’s percep-
tions that distress caused by the condition is not taken 
seriously.
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Table 3 Online resources for people with vitiligo
Web site URL
NHS Choices http://www.nhs.uk/conditions/Vitiligo/Pages/Introduction.aspx
Links to the official web site of the National Health Service in England. Their section on vitiligo provides 
information and advice about vitiligo symptoms, causes, diagnosis and treatments.
Patient.co.uk http://patient.info/health/vitiligo-leaflet
Links to a general medical information and support web site providing information and advice about 
vitiligo symptoms, causes and treatments
The Vitiligo Society http://www.vitiligosociety.org.uk/
Links to The Vitiligo Society web site, a UK-based charity providing information and support for people 
with vitiligo through their regularly updated web site and newsletter, Dispatches
copyright.
 o
n
 O
ctober 21, 2019 at University of Nottingham
. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018652 on 11 January 2018. Downloaded from 
 7Teasdale E, et al. BMJ Open 2018;8:e018652. doi:10.1136/bmjopen-2017-018652
Open Access
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
reFerenCes
 1. Osinubi O, Grainge MJ, Hong L, et al. The prevalence of 
psychological co-morbidity in people with vitiligo: a systematic 
review and meta-analysis. Br J Dermatol 2017.
 2. Zhang Y, Cai Y, Shi M, et al. The prevalence of vitiligo: a meta-
analysis. PLoS One 2016;11:e0163806.
 3. Porter JR, Beuf AH, Lerner A, et al. Psychosocial effect of vitiligo: a 
comparison of vitiligo patients with "normal" control subjects, with 
psoriasis patients, and with patients with other pigmentary disorders. 
J Am Acad Dermatol 1986;15:220–4.
 4. Radtke MA, Schäfer I, Gajur A, et al. Willingness-to-pay and quality 
of life in patients with vitiligo. Br J Dermatol 2009;161:134–9.
 5. Silverberg JI, Silverberg NB. Quality of life impairment in children and 
adolescents with vitiligo. Pediatr Dermatol 2014;31:309–18.
 6. Whitton ME, Pinart M, Batchelor J, et al. Interventions for vitiligo. 
Cochrane Database Syst Rev 2010:CD003263.
 7. Taieb A, Alomar A, Böhm M, et al. Guidelines for the management of 
vitiligo: the European Dermatology Forum consensus. Br J Dermatol 
2013;168:5–19.
 8. Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: 
a survey of members of the Vitiligo Society. Clin Exp Dermatol 
2010;35:736–9.
 9. Thompson AR, Kent G, Smith JA. Living with vitiligo: dealing with 
difference. Br J Health Psychol 2002;7(Pt 2):213–25.
 10. Thompson AR, Clarke SA, Newell RJ, et al. Vitiligo linked to 
stigmatization in British South Asian women: a qualitative study of 
the experiences of living with vitiligo. Br J Dermatol 2010;163:481–6.
 11. Ezzedine K, Sheth V, Rodrigues M, et al. Vitiligo is not a cosmetic 
disease. J Am Acad Dermatol 2015;73:883–5.
 12. Nelson PA. Getting under the skin: qualitative methods in 
dermatology research. Br J Dermatol 2015;172:841–3.
 13. Bishop FL, Howick J, Heneghan C, et al. Placebo use in the UK: a 
qualitative study exploring GPs' views on placebo effects in clinical 
practice. Fam Pract 2014;31:357–63.
 14. Corner J, Wagland R, Glaser A, et al. Qualitative analysis of patients’ 
feedback from a PROMs survey of cancer patients in England. BMJ 
Open 2013;3:e002316.
 15. Richards SH, Campbell JL, Walshaw E, et al. A multi-method 
analysis of free-text comments from the UK General Medical Council 
Colleague Questionnaires. Med Educ 2009;43:757–66.
 16. Joffe H, Yardley L. Content and thematic analysis. In: Research 
Methods for Clinical and Health Psychology. London, UK: Sage, 
2004:56–68.
 17. Naik A. Vitiligo: compilation of clinico-epidemiological features 
in patients attending tertiary care government hospital, Thane. 
Australas Med J 2010;3:826–32.
 18. Reghu R, James E. Epidemiological profile and treatment pattern 
of vitiligo in a tertiary care teaching hospital. Int J Pharm Sci 
2011;3:137–41.
 19. Magin PJ, Adams J, Heading GS, et al. Patients with skin 
disease and their relationships with their doctors: a qualitative 
study of patients with acne, psoriasis and eczema. Med J Aust 
2009;190:62–4.
 20. Nelson PA, Chew-Graham CA, Griffiths CE, et al. Recognition of 
need in health care consultations: a qualitative study of people with 
psoriasis. Br J Dermatol 2013;168:354–61.
 21. Santer M, Muller I, Yardley L, et al. 'You don't know which bits to 
believe’: qualitative study exploring carers’ experiences of seeking 
information on the internet about childhood eczema. BMJ Open 
2015;5:e006339.
 22. Sillence E, Briggs P, Harris PR, et al. How do patients evaluate 
and make use of online health information? Soc Sci Med 
2007;64:1853–62.
 23. Eleftheriadou V, Whitton ME, Gawkrodger DJ, et al. Future research 
into the treatment of vitiligo: where should our priorities lie? 
Results of the vitiligo priority setting partnership. Br J Dermatol 
2011;164:no–36.
 24. APPGS. 2013. The psychological and social impact of skin diseases 
on people’s lives. A report of the all party parliamentary group on 
skin updated 2013 edition: London.
 25. Greenfield G, Foley K, Majeed A. Rethinking primary care's 
gatekeeper role. BMJ 2016;354:i4803.
 26. Mazanderani F, Powell J. Using the internet as a source of 
information about patients’ experiences. Understanding and Using 
Health Experiences: Improving patient care, 2013:94–103.
copyright.
 o
n
 O
ctober 21, 2019 at University of Nottingham
. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018652 on 11 January 2018. Downloaded from 
